发明公开
- 专利标题： NOVEL INFLUENZA ANTIGENS AND ANTIBODIES
- 专利标题（中）： 新型流感抗原和抗体
-
申请号： EP14777272.7申请日： 2014-08-26
-
公开(公告)号： EP3039036A1公开(公告)日： 2016-07-06
- 发明人: STEVENS, James , DONIS, Ruben , SHORE, David , WAN, Hongquan , VASSILEV, Ventzislav Bojidarov
- 申请人： GlaxoSmithKline Biologicals S.A. , The United States of America, as represented by The Secretary, Department of Health and Human Services
- 申请人地址： Rue de l'Institut, 89 1330 Rixensart Brussels BE
- 专利权人： GlaxoSmithKline Biologicals S.A.,The United States of America, as represented by The Secretary, Department of Health and Human Services
- 当前专利权人： GlaxoSmithKline Biologicals S.A.,The United States of America, as represented by The Secretary, Department of Health and Human Services
- 当前专利权人地址： Rue de l'Institut, 89 1330 Rixensart Brussels BE
- 代理机构： West, Heloise
- 优先权： US201361870862P 20130828
- 国际公布： WO2015028478 20150305
- 主分类号： C07K16/10
- IPC分类号： C07K16/10 ; A61K39/145
摘要：
Novel influenza antigens, novel immunogenic or vaccine compositions, as well as uses of and methods for producing said antigens and compositions, are described.
公开/授权文献
- EP3039036B1 NOVEL INFLUENZA ANTIGENS AND ANTIBODIES 公开/授权日：2019-05-22
信息查询
